Xeris Biopharma Holdings, Inc. (XERS) Operating Leases, Future Minimum Payments, Due in Three Years USD 2021 - 2022

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
Summary
Xeris Biopharma Holdings, Inc. quarterly Operating Leases, Future Minimum Payments, Due in Three Years history and growth rate from 2021 to 2022.
  • Xeris Biopharma Holdings, Inc. Operating Leases, Future Minimum Payments, Due in Three Years for the quarter ending September 30, 2022 was $6.08 M, a 199% increase year-over-year.
Operating Leases, Future Minimum Payments, Due in Three Years, Quarterly (USD)
Operating Leases, Future Minimum Payments, Due in Three Years, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $6.08 M +$4.05 M +199% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $1.98 M Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $1.98 M Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $1.98 M Dec 31, 2021 10-K 2023-03-08
Q3 2021 $2.03 M Sep 30, 2021 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.